Last checked at LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:
----------
FTSE 100
----------
BERENBERG CUTS TRAVIS PERKINS PRICE TARGET TO 1800 (1880) PENCE - 'HOLD'
----------
JEFFERIES CUTS LAND SECURITIES TO 'HOLD' ('BUY') - PRICE TARGET 1112 PENCE
----------
JEFFERIES CUTS BRITISH LAND TO 'HOLD' ('BUY')
----------
BERNSTEIN CUTS MORRISON PRICE TARGET TO 220 (270) PENCE - 'MARKET-PERFORM'
----------
CITIGROUP RAISES ASHTEAD GROUP PRICE TARGET TO 1075 (850) PENCE - 'BUY'
----------
GOLDMAN CUTS PERSIMMON TO 'BUY' ('CONVICTION BUY LIST')
----------
MORGAN STANLEY RAISES SHELL PRICE TARGET TO 2500 (2330) PENCE - 'EQUAL-WEIGHT'
----------
MORGAN STANLEY RAISES BP PRICE TARGET TO 525 (490) PENCE - 'EQUAL-WEIGHT'
----------
GOLDMAN RAISES SPORTS DIRECT PRICE TARGET TO 1100 (980) PENCE - 'CL BUY'
----------
CHARLES STANLEY CUTS ADMIRAL GROUP TO 'REDUCE' ('HOLD')
----------
FTSE 250
----------
BERENBERG RAISES CLOSE BROTHERS PRICE TARGET TO 1640 (1330) PENCE - 'BUY'
----------
NUMIS RAISES CLOSE BROTHERS PRICE TARGET TO 1325 (1214) PENCE - 'HOLD'
----------
JPMORGAN RAISES CLOSE BROTHERS PRICE TARGET TO 1480 (1357) PENCE - 'OVERWEIGHT'
----------
UBS RAISES CLOSE BROTHERS PRICE TARGET TO 1420 (1340) PENCE - 'NEUTRAL'
----------
UBS CUTS FENNER PRICE TARGET TO 480 (500) PENCE - 'BUY'
----------
JEFFERIES CUTS FENNER PRICE TARGET TO 490 (505) PENCE - 'BUY'
----------
UBS RAISES KAZAKHMYS PRICE TARGET TO 300 (210) PENCE - 'NEUTRAL'
----------
UBS CUTS N BROWN TO 'SELL' ('NEUTRAL') - TARGET 535 (565) PENCE
----------
UBS CUTS PREMIER FARNELL PRICE TARGET TO 235 (240) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS RIGHTMOVE TO 'BUY' ('CONVICTION BUY LIST')
----------
GOLDMAN CUTS BARRATT DEVELOPMENTS TO 'NEUTRAL' ('BUY')
----------
GOLDMAN RAISES REDROW TO 'BUY' ('NEUTRAL')
----------
DEUTSCHE BANK CUTS GO-AHEAD GROUP TO 'HOLD' ('BUY') - TARGET 2100 (1640) PENCE
----------
DEUTSCHE BANK RAISES ESURE GROUP PRICE TARGET TO 313 (300) PENCE - 'BUY'
----------
CANACCORD CUTS ESURE GROUP PRICE TARGET TO 295 (305) PENCE - 'BUY'
----------
CITIGROUP RAISES ESURE GROUP PRICE TARGET TO 294 (291) PENCE - 'BUY'
----------
NOMURA RAISES INCHCAPE PRICE TARGET TO 600 (580) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK RAISES INCHCAPE PRICE TARGET TO 685 (655) PENCE - 'BUY'
----------
INVESTEC CUTS HUNTING TO 'HOLD' ('BUY')
----------
JPMORGAN RAISES MERLIN PRICE TARGET TO 430 (415) PENCE - 'OVERWEIGHT'
----------
JEFFERIES RAISES CAPITAL & COUNTIES PRICE TARGET TO 362 (294) PENCE - 'HOLD'
----------
GOLDMAN RAISES CREST NICHOLSON TO 'CONVICTION BUY LIST' ('BUY')
----------
GOLDMAN RAISES BOVIS HOMES PRICE TARGET TO 1187 (1070) PENCE - 'BUY'
----------
GOLDMAN CUTS SAVILLS PRICE TARGET TO 719 (771) PENCE - 'NEUTRAL'
----------
PANMURE CUTS HIKMA PHARMACEUTICALS TO 'HOLD' ('BUY') - TARGET 1400 (1375) PENCE
----------
MAIN MARKET AND AIM
----------
GOLDMAN RAISES LSL PROPERTY SERVICES PRICE TARGET TO 642 (626) PENCE - 'BUY'
----------
CANACCORD CUTS ROCKHOPPER EXPLORATION PRICE TARGET TO 265 (345) PENCE - 'BUY'
----------
CANACCORD CUTS BROOKS MACDONALD TO 'HOLD' ('BUY') - TARGET 1780 (1620) PENCE
----------
NUMIS RAISES TYMAN PRICE TARGET TO 320 (285) PENCE - 'ADD'
----------
CANACCORD RAISES CAPE PLC PRICE TARGET TO 360 (300) PENCE - 'BUY'
----------
NUMIS CUTS MODERN WATER PRICE TARGET TO 62 (77) PENCE - 'BUY'
----------
PANMURE RAISES PHOENIX IT TO 'BUY' ('HOLD') - TARGET 136 (144) PENCE
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.
20 Apr 2022 09:16
IN BRIEF: Hikma gets preliminary US approval for Custopharm acquisition
Hikma Pharmaceuticals PLC - London-based generic drugmaker - Receives preliminary approval from the US Federal Trade Commission for its planned acquisition of Custopharm Inc. Back in September, Hikma agreed to buy the California, US-based generic injectable products company for a total of up to USD425 million.
Read more